AIM: Angelman syndrome is a neurogenetic disorder characterized by severe intellectual disability, absent speech, seizures, and outbursts of laughter. The aim of this study was to utilize diffusion tensor imaging (DTI) to examine alterations in white matter pathways in Angelman syndrome, with an emphasis on correlations with clinical severity. METHOD: DTI was used to examine the arcuate fasciculus (AF), uncinate fasciculus (UF), inferior longitudinal fasciculus (ILF), inferior fronto-occipital fasciculus (IFOF), and the corpus callosum (CC). We enrolled 14 children aged 8 to 17 years (mean age 10y 8mo; SD 2y 7mo) with Angelman syndrome (seven male; seven female) and 13 typically developing children, aged 8 to 17 years, for comparison (five male; eight female; mean age 12y; SD 2y 9mo). Individuals with Angelman syndrome were assessed using standardized measures of development, language, and behaviour. RESULTS: The children with Angelman syndrome exhibited lower fractional anisotropy and increased radial diffusivity values than the comparison group for the AF, UF, ILF, and CC (p < 0.006 corrected for multiple comparisons). They also had lower fractional anisotropy values for the IFOF and higher radial diffusivity values for the left IFOF (p < 0.006). Additionally, children with Angelman syndrome had significantly higher apparent diffusion coefficient values in the AF, CC, ILF, and the left IFOF (p < 0.006). Significant correlations were noted between DTI parameters and some of the clinical assessment outcomes (e.g. language, socialization, cognition) for three of the temporal pathways (AF, UF, ILF; p < 0.05). INTERPRETATION: Changes in DTI parameters in individuals with Angelman syndrome suggest decreased/delayed myelination, decreased axonal density or diameter, or aberrant axonal organization. Our findings suggest a generalized white matter alteration throughout the brain in those with Angelman syndrome; however, only the alterations in temporal white matter pathways were associated with language and cognitive and social functioning.
AIM: Angelman syndrome is a neurogenetic disorder characterized by severe intellectual disability, absent speech, seizures, and outbursts of laughter. The aim of this study was to utilize diffusion tensor imaging (DTI) to examine alterations in white matter pathways in Angelman syndrome, with an emphasis on correlations with clinical severity. METHOD: DTI was used to examine the arcuate fasciculus (AF), uncinate fasciculus (UF), inferior longitudinal fasciculus (ILF), inferior fronto-occipital fasciculus (IFOF), and the corpus callosum (CC). We enrolled 14 children aged 8 to 17 years (mean age 10y 8mo; SD 2y 7mo) with Angelman syndrome (seven male; seven female) and 13 typically developing children, aged 8 to 17 years, for comparison (five male; eight female; mean age 12y; SD 2y 9mo). Individuals with Angelman syndrome were assessed using standardized measures of development, language, and behaviour. RESULTS: The children with Angelman syndrome exhibited lower fractional anisotropy and increased radial diffusivity values than the comparison group for the AF, UF, ILF, and CC (p < 0.006 corrected for multiple comparisons). They also had lower fractional anisotropy values for the IFOF and higher radial diffusivity values for the left IFOF (p < 0.006). Additionally, children with Angelman syndrome had significantly higher apparent diffusion coefficient values in the AF, CC, ILF, and the left IFOF (p < 0.006). Significant correlations were noted between DTI parameters and some of the clinical assessment outcomes (e.g. language, socialization, cognition) for three of the temporal pathways (AF, UF, ILF; p < 0.05). INTERPRETATION: Changes in DTI parameters in individuals with Angelman syndrome suggest decreased/delayed myelination, decreased axonal density or diameter, or aberrant axonal organization. Our findings suggest a generalized white matter alteration throughout the brain in those with Angelman syndrome; however, only the alterations in temporal white matter pathways were associated with language and cognitive and social functioning.
Authors: Motoaki Nakamura; Robert W McCarley; Marek Kubicki; Chandlee C Dickey; Margaret A Niznikiewicz; Martina M Voglmaier; Larry J Seidman; Stephan E Maier; Carl-Fredrik Westin; Ron Kikinis; Martha E Shenton Journal: Biol Psychiatry Date: 2005-06-22 Impact factor: 13.382
Authors: Charles A Williams; Arthur L Beaudet; Jill Clayton-Smith; Joan H Knoll; Martin Kyllerman; Laura A Laan; R Ellen Magenis; Ann Moncla; Albert A Schinzel; Jane A Summers; Joseph Wagstaff Journal: Am J Med Genet A Date: 2006-03-01 Impact factor: 2.802
Authors: Vivian Mitropoulou; Phillip D Harvey; Liza A Maldari; Patrick J Moriarty; Antonia S New; Jeremy M Silverman; Larry J Siever Journal: Biol Psychiatry Date: 2002-12-15 Impact factor: 13.382
Authors: Elisabeth A Wilde; Zili Chu; Erin D Bigler; Jill V Hunter; Michael A Fearing; Gerri Hanten; Mary R Newsome; Randall S Scheibel; Xiaoqi Li; Harvey S Levin Journal: J Neurotrauma Date: 2006-10 Impact factor: 5.269
Authors: Sai Prasad Gopal; Vijay Narayan Tiwari; Amy L Veenstra; Ajay Kumar; Michael Behen; Harry T Chugani; Senthil K Sundaram Journal: J Pediatr Date: 2011-08-11 Impact factor: 4.406
Authors: Vijay N Tiwari; Jeong-won Jeong; Benjamin J Wilson; Michael E Behen; Harry T Chugani; Senthil K Sundaram Journal: Neuroimage Date: 2011-07-30 Impact factor: 6.556
Authors: Matthew C Judson; Alain C Burette; Courtney L Thaxton; Alaine L Pribisko; Mark D Shen; Ashley M Rumple; Wilmer A Del Cid; Beatriz Paniagua; Martin Styner; Richard J Weinberg; Benjamin D Philpot Journal: J Neurosci Date: 2017-06-29 Impact factor: 6.167
Authors: Mar Jiménez de la Peña; Ana Jiménez de Domingo; Pilar Tirado; Beatriz Calleja-Pérez; Luis A Alcaraz; Sara Álvarez; Jonathan Williams; James R Hagman; Andrea H Németh; Alberto Fernández-Jaén Journal: Mol Syndromol Date: 2021-04-09